Cerenis Therapeutics
HealthcareBiotech & Pharma
HQ: Toulouse, France
Investors: 1
HDL-mimetic therapies for lipid disorders
Investors (1)
| Fund | Status | Entry Date | Stage | Source |
|---|---|---|---|---|
| Sofinnova Partners | Exited | - | - | Website |
Get these signals delivered weekly
Deals, exits, fundraises, and key hires from funds active in Italy — straight to your inbox.
Get Signals